A detailed history of Ransom Advisory, LTD transactions in Pfizer Inc stock. As of the latest transaction made, Ransom Advisory, LTD holds 19,749 shares of PFE stock, worth $495,304. This represents 0.2% of its overall portfolio holdings.

Number of Shares
19,749
Previous 21,148 6.62%
Holding current value
$495,304
Previous $539 Million 99.91%
% of portfolio
0.2%
Previous 0.24%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 06, 2026

SELL
$24.23 - $27.37 $33,897 - $38,290
-1,399 Reduced 6.62%
19,749 $495,000
Q3 2025

Oct 07, 2025

BUY
$23.29 - $25.88 $492,536 - $547,310
21,148 New
21,148 $539 Million
Q3 2025

Oct 03, 2025

SELL
$23.29 - $25.88 $492,350 - $547,103
-21,140 Closed
0 $539 Million
Q2 2025

Jul 08, 2025

BUY
$21.59 - $24.84 $151 - $173
7 Added 0.03%
21,140 $512 Million
Q1 2025

May 20, 2025

BUY
$25.01 - $27.13 $528,536 - $573,338
21,133 New
21,133 $536 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ransom Advisory, LTD Portfolio

Follow Ransom Advisory, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ransom Advisory, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ransom Advisory, LTD with notifications on news.